Guido Valente

Guido Valente is an Associate Professor in the Department of Translational Medicine at the University of Eastern Piedmont "Amedeo Avogadro", with a prolific research career spanning over 40 years and 187 publications focused on cancer biology and molecular pathology.

His research expertise centers on neoplasms, metastatic carcinoma, and biomarker analysis (notably Ki-67), with significant contributions to understanding Head-and-neck Squamous Cell Carcinoma and monoclonal antibody applications. Current investigations explore lysine demethylase targets in colorectal cancer and molecular profiles of brain metastasis.

Recent publications (2023-2024) demonstrate interdisciplinary reach across pulmonology, stem cell metabolism, rheumatology, and oral pathology, reflecting a translational approach connecting molecular mechanisms to clinical outcomes in oncology and rare diseases.

Scientific Awards: No awards were documented in the source material.

Dr. Valente has secured competitive funding for projects including "Investigation of Lysine Demethylase 1A as a novel drug target for colorectal carcinoma" (2017-2019) and "Identification of molecular profiles for brain metastasis", collaborating with researchers like D. Capello and G. Pelicci. His mentorship extends through project leadership though formal student lists weren't provided.

He maintains an active research network visualized through international collaborations, particularly in oncology consortia focusing on molecular diagnostics and therapeutic target identification.